80 related articles for article (PubMed ID: 10193827)
21. Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis.
Sethi D; Murphy CM; Brown EA; Müller BR; Gower PE
Nephron; 1989; 52(4):352-5. PubMed ID: 2671763
[TBL] [Abstract][Full Text] [Related]
22. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT
Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
[TBL] [Abstract][Full Text] [Related]
24. [Concentration of leptin in patients on hemodialysis and peritoneal dialysis].
Zbroch E; Małyszko J; Wołczyński S; Hryszko T; Myśliwiec M
Pol Arch Med Wewn; 1999 Jun; 101(6):503-8. PubMed ID: 10754736
[TBL] [Abstract][Full Text] [Related]
25. Effect of peritoneal glucose load on plasma leptin concentration in continuous ambulatory peritoneal dialysis patients.
Kim MJ; Kim GA; Lee SW; Song JH; Hyun IY
Yonsei Med J; 2000 Aug; 41(4):485-90. PubMed ID: 10992810
[TBL] [Abstract][Full Text] [Related]
26. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
27. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients.
Balafa O; Halbesma N; Struijk DG; Dekker FW; Krediet RT
Clin J Am Soc Nephrol; 2011 Mar; 6(3):561-6. PubMed ID: 21071518
[TBL] [Abstract][Full Text] [Related]
30. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
31. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
32. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
Lai KN; Lai KB; Szeto CC; Lam CW; Leung JC
Am J Nephrol; 1999; 19(3):416-22. PubMed ID: 10393381
[TBL] [Abstract][Full Text] [Related]
33. Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.
Bernardo AP; Oliveira JC; Santos O; Carvalho MJ; Cabrita A; Rodrigues A
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2205-12. PubMed ID: 26507143
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.
Zemel D; ten Berge RJ; Struijk DG; Bloemena E; Koomen GC; Krediet RT
Clin Nephrol; 1992 Feb; 37(2):97-103. PubMed ID: 1551256
[TBL] [Abstract][Full Text] [Related]
35. The effect of glucose polymers on water removal and protein clearances during CAPD.
Imholz AL; Brown CB; Koomen GC; Arisz L; Krediet RT
Adv Perit Dial; 1993; 9():25-30. PubMed ID: 7692975
[TBL] [Abstract][Full Text] [Related]
36. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis.
Joffe P; Henriksen JH
Nephrol Dial Transplant; 1995; 10(9):1725-32. PubMed ID: 8559496
[TBL] [Abstract][Full Text] [Related]
37. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure.
Stenvinkel P; Heimbürger O; Lönnqvist F
Nephrol Dial Transplant; 1997 Jul; 12(7):1321-5. PubMed ID: 9249764
[TBL] [Abstract][Full Text] [Related]
38. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure.
Heimbürger O; Lönnqvist F; Danielsson A; Nordenström J; Stenvinkel P
J Am Soc Nephrol; 1997 Sep; 8(9):1423-30. PubMed ID: 9294834
[TBL] [Abstract][Full Text] [Related]
39. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
[TBL] [Abstract][Full Text] [Related]
40. Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
Nakamoto H; Imai H; Kawanishi H; Nakamoto M; Minakuchi J; Kumon S; Watanabe S; Shiohira Y; Ishii T; Kawahara T; Suzuki H
Adv Perit Dial; 2001; 17():238-43. PubMed ID: 11510284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
